Skip to content
Open access

In vitro Evaluation of α-Amylase and α-Glucosidase Inhibitory Activities of Salvia rosmarinus

Oct 2026 · Research journal of biotechnology · 0 citations

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycaemia resulting from impaired insulin secretion, insulin action, or both. Plant-derived bioactive compounds have gained increasing attention as safer alternatives for managing diabetes due to their antioxidant and antihyperglycaemic properties. Salvia rosmarinus (rosemary) is a medicinal herb rich in phytochemicals with diverse pharmacological activities. This study investigated the phytochemical composition and in vitro antidiabetic potential of Salvia rosmarinus hexane leaf extract and evaluated the phytopharmacological and antihyperglycaemic activities of Salvia rosmarinus through GC–MS profiling, antioxidant assays, enzyme inhibition studies, cell-based investigations and insulinsignalling gene expression analysis. Hexane extract of Salvia rosmarinus leaves was prepared and was characterized using GC–MS. Antioxidant activity was determined by the DPPH free radical scavenging assay. Antidiabetic activity was evaluated through αamylase and α-glucosidase inhibition assays. Cytoprotective effects were assessed in HepG2 and 3T3-L1 cells under high-glucose conditions using the MTT assay. The expression of insulin-signalling genes (IR, IRS-1/2, AKT1, AS160 and GLUT-4) was quantified by RT-PCR. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. GC–MS analysis identified 32 compounds, including phenethyl phenylacetate (32.83%), isopropyl tetradecanoate (17.05%) and hexadecanoic acid (7.59%) as the major constituents. The extract exhibited notable antioxidant activity with a DPPH IC₅₀ of 25.62 µg/mL. It also demonstrated significant αamylase (IC₅₀ = 21.03 µM) and α-glucosidase (IC₅₀ = 20.02 µM) inhibitory activities. In high-glucoseinduced HepG2 and 3T3-L1 cells, the extract improved cell viability, reduced cytotoxicity, enhanced glucose utilization and significantly upregulated IR, IRS-1/2, AKT1, AS160 and GLUT-4 gene expression, indicating improved insulin signalling. Salvia rosmarinus hexane extract demonstrated promising antioxidant and antihyperglycaemic activities by inhibiting carbohydrate-hydrolysing enzymes, protecting cells against glucose-induced damage and enhancing insulin-signalling pathways. These findings suggest that Salvia rosmarinus possesses significant potential as a natural therapeutic candidate for diabetes management and warrants further in vivo and clinical investigations.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.